MBRX - Moleculin Biotech, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 551.07M
Enterprise Value 325.11M
Trailing P/E N/A
Forward P/E 1-2.69
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.24
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.49

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-45.86%
Return on Equity (ttm)-79.37%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -16.88M
Net Income Avi to Common (ttm)-13.99M
Diluted EPS (ttm)-0.5150
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.78M
Total Cash Per Share (mrq)0.3
Total Debt (mrq)180k
Total Debt/Equity (mrq)1.23
Current Ratio (mrq)1.49
Book Value Per Share (mrq)0.50

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-29.27%
S&P500 52-Week Change 34.96%
52 Week High 33.1500
52 Week Low 30.7772
50-Day Moving Average 31.2243
200-Day Moving Average 31.2769

Share Statistics

Avg Vol (3 month) 33.76M
Avg Vol (10 day) 3752.67k
Shares Outstanding 545.19M
Float 19.71M
% Held by Insiders 123.73%
% Held by Institutions 111.23%
Shares Short (Apr 30, 2019) 43.41M
Short Ratio (Apr 30, 2019) 40.35
Short % of Float (Apr 30, 2019) 412.43%
Short % of Shares Outstanding (Apr 30, 2019) 49.93%
Shares Short (prior month Mar 29, 2019) 4793.57k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A